ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1482	National Cancer Institute	Html	en	Thyroid Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of thyroid cancer.	NX Regional lymph 0.514232 differentiated thyroid carcinoma 0.483242 thyroid capsule 0.458348 lymph node recurrence 0.424478 lymph node involvement. 0.433258 thyroid carcinoma 0.494127 follicular thyroid carcinoma 0.43746 minimal extrathyroid extension 0.497486 papillary thyroid cancer 0.500545 recurrent differentiated thyroid 0.423584 perithyroid soft tissues 0.49864 M0 T2 Tumor 0.418332 N1a Metastases 0.452974 patients 0.4225 lymph node biopsy 0.465877 sentinel lymph node 0.465511 thyroid cancer. 0.408942 encases carotid artery 0.459248 lymph nodes 0.70121 papillary thyroid microcarcinomas 0.421769 papillary thyroid carcinoma 0.467474 prelaryngeal/Delphian lymph nodes 0.599278 T1b Tumor 0.476542 thyroid diseases 0.408003	T1a Tumor 0.476741 thyroid gland 0.406975 thyroid cancer 0.570421 mediastinal lymph nodes 0.577558 thyroid autoantibodies 0.408316 greatest dimension 0.710356 follicular thyroid cancer 0.472046 subcutaneous soft tissues 0.453725 soft tissues 0.502801 recurrent laryngeal nerve 0.458581 superior mediastinal lymph 0.567495 tumor suppressor gene 0.41425 regional lymph node 0.969698 distant metastasis 0.429776 TX Primary tumor 0.476275 cm 0.593737 primary tumor 0.496822 lymph node status 0.43297 differentiated thyroid cancer 0.496492 lymph node involvement 0.43209 M0 T1 Tumor 0.448756 tumor 0.667722 regional lymph nodes 0.569893 lymph node metastases 0.446319	CLICK HERE
1540	National Cancer Institute	Html	en	Levels of Evidence for Human Studies of Integrative, Alternative, and Complementary Therapies (PDQ®)–Health Professional Version	Information about how to weigh the strength of the evidence obtained in human studies of integrative, alternative, and complementary therapies for cancer.	strength 0.674769 evidence score 0.330764 clinical details 0.253336 strongest endpoint 0.346454 weak study design 0.389561 PDQ cancer information 0.609434 PDQ information 0.33766 Best Case Series 0.34796 clinical trials 0.245761 cancer information summary 0.520348 human studies 0.415104 breast cancer prevention 0.370124 numeric scale 0.249195 randomized trial 0.254175 study types 0.251887 study design 0.95862 design categories yields 0.398085 NCI’s PDQ 0.357199 cancer treatment studies 0.394746 PDQ Adult Treatment 0.532483 NCI PDQ cancer 0.476778 weakest design 0.286828 statistical strength 0.648901 complementary therapies 0.394252 human cancer 0.391957	proper assessment 0.249946 Therapies Editorial Board 0.336527 PDQ Integrative 0.333821 strongest design 0.2759 different treatments 0.250238 clinical findings 0.245005 case series 0.380662 progressive alphabetic scale 0.362349 similar results 0.25211 therapeutic endpoint 0.358766 Cause-specific mortality 0.243515 endpoint 0.41291 individual case reports 0.382311 particular treatments 0.266483 total mortality 0.246905 scientific strength 0.586275 National Cancer Institute 0.778424 Editorial Board 0.404104 PDQ documents 0.331784 various types 0.248384 anecdotal reports 0.254781 cancer-related images 0.244704 tumor response 0.253792 stronger study design 0.404144	CLICK HERE
1556	National Cancer Institute	Html	en	Colorectal Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing of colorectal cancer and about research aimed at the prevention of this disease.	cancer treatment 0.462885 cancer prevention trials 0.5302 colorectal cancer prevention 0.614686 colorectal polyps 0.56189 protective factors 0.497455 following PDQ summaries 0.48755 PDQ cancer information 0.608246 new colorectal cancers 0.563344 clinical trials 0.59581 possible harms 0.498355 increased risk 0.474738 cancer information summary 0.540977 risk factors 0.560326 breast cancer prevention 0.482223 colorectal cancer 0.972144 new colorectal cancer 0.620653 lower risk 0.461958 cancer patients 0.460978 nonpolyposis colon cancer 0.4955 cancer risk factor 0.521529 colon cancer prevention 0.494063 NCI’s PDQ 0.461756 Clinical Trials section 0.458686 smaller polyps lowers 0.458496	NCI PDQ cancer 0.516757 rectal cancer prevention 0.488321 large colorectal adenomas 0.566232 hormone replacement therapy 0.492755 familial adenomatous polyposis 0.499723 cancer risk factors 0.517883 colorectal adenomas 0.616144 cancer protective factor 0.49566 Cancer Information Service 0.487513 prevention clinical trials 0.487754 Prevention Editorial Board 0.488084 treatment clinical trials 0.458488 National Cancer Institute 0.559763 cancer doctors 0.458093 colorectal cancer cases 0.619218 colon cancer 0.508406 Cancer Care page 0.480229 PDQ database 0.45787 PDQ summary 0.478855 invasive colorectal cancer 0.6296 cancer clinical trials 0.495703 cancer information summaries 0.492581 comprehensive cancer information 0.492387 risk 0.615513	CLICK HERE
1582	National Cancer Institute	Html	en	Adult Soft Tissue Sarcoma Treatment (PDQ®)–Patient Version	Soft tissue sarcomas can form almost anywhere in the body, but are most common in the head, neck, arms, legs, truck, and abdomen. Find out about risk and genetic factors, symptoms, tests to diagnose, prognosis, staging, and treatment for soft tissue sarcoma.	cancer treatment 0.262443 malignant tumor cells 0.254786 cancer spreads 0.245112 body 0.294182 type 0.25634 PDQ cancer information 0.274383 clinical trial search 0.274958 clinical trials 0.461076 nearby lymph nodes 0.239706 cancer information summary 0.260539 clinical trial 0.328582 patients 0.25186 blood vessels 0.240907 treatment clinical trial 0.238552 subcutaneous tissue 0.292398 NCI PDQ cancer 0.240642 Treatment Option Overview 0.242732 lymph nodes 0.261315 radiation therapy 0.391981 little normal tissue 0.262689 soft tissue sarcoma 0.92025 General information 0.241563 treatment 0.357792 wide local excision 0.284219 nearby healthy tissue 0.249677	NCI-supported cancer 0.247977 cancer cells 0.331726 laboratory test 0.23958 soft tissues 0.24063 connective tissue 0.264853 treatment clinical trials 0.254055 National Cancer Institute 0.283258 soft tissue sarcomas 0.301359 new treatment 0.260355 adult soft tissue 0.678017 tissue sarcoma cells 0.278793 external radiation therapy 0.248848 primary tumor 0.244329 metastatic tumor 0.239026 tissue samples 0.246374 Regional hyperthermia therapy 0.239395 cancer clinical trials 0.280749 stage 0.259627 tumor 0.3265 Tissue Sarcoma Treatment 0.274121 treatment options 0.240625 internal radiation therapy 0.238752 cancer 0.489567 information 0.283228	CLICK HERE
1743	National Cancer Institute	Html	en	Photodynamic Therapy for Cancer	A fact sheet that explains photodynamic therapy, how it is administered, and indications and side effects of treatment.	cancer treatment 0.467161 skin cancer 0.463524 agent 0.509208 necessary nutrients 0.453814 blood cancers 0.455343 activating light 0.500969 cutaneous T-cell lymphoma 0.497644 surface tumors 0.462582 body 0.47526 different areas 0.455534 light sources 0.464075 healthy tissue 0.483908 bright indoor light 0.598285 U.S. Food 0.516598 specific wavelength 0.502289 certain cancers 0.465708 patients 0.455008 blood cells 0.468142 photosensitizing agent 0.45652 non-small cell lung 0.667463 photosensitizer 0.466135 symptoms 0.456503 particular type 0.455996 direct sunlight 0.514024 specific type 0.457687	treatment 0.479989 esophageal cancer 0.492936 photodynamic therapy 0.576544 nearby healthy tissue 0.481898 skin 0.463697 Drug Administration 0.510947 active form 0.454418 cancer cells 0.690083 fiber optic cable 0.49481 Barrett esophagus 0.454031 photosensitizers 0.460437 tumor cells 0.475849 normal cells 0.508255 PDT 0.970829 Extracorporeal photopheresis 0.455159 large tumors 0.503661 porfimer sodium 0.78695 fiber optic cables 0.493403 light-emitting diodes 0.456906 nearby cells 0.473123 tumors 0.505296 Laser light 0.464403 cell lung cancer 0.646935 nearby cancer cells 0.527607	CLICK HERE
1775	National Cancer Institute	Html	es	Náuseas y vómitos relacionados con el tratamiento (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las náuseas y los vómitos como complicaciones a causa del cáncer o su tratamiento. Se describen abordajes de tratamiento de las náuseas y los vómitos.	chemotherapy induced nausea 0.342573 conditioned nausea 0.336948 Bouganim N 0.33134 delayed chemotherapy-induced nausea 0.334556 anticipatory nausea 0.772561 schwartzberg ls 0.356266 horas vo 0.591535 Krozely MG 0.34156 Hesketh PJ 0.353455 colorectal cancer 0.336446 chemotherapy-induced nausea 0.951327 dosis vo 0.347133 continuación presente nva 0.332752 mg vr 0.340801 community clinical practices 0.338332 anticipatory emesis 0.337674 cancer chemotherapy 0.773091 Pain Symptom Manage 0.361458 Support Oncol 0.346357 quimioterapia categoría 0.357422 Roscoe JA 0.415752 NyV agudos 0.347107 mg im 0.432997 NVIQ agudos 0.337444 controlling chemotherapy-induced nausea 0.364663	delayed nausea 0.337245 Care Cancer 0.464148 Bovbjerg DH 0.349781 VO Inhibidor 0.357448 mg vo 0.767769 quimioterapia vo 0.485969 Kris MG 0.406292 quimioterapia vo la 0.389831 significant clinical problem 0.339573 Prospective validation 0.334589 Consult Clin Psychol 0.417355 clinical oncology 0.347599 quimioterapia iv 0.373245 Hickok JT 0.353347 días vo inhibidor 0.344362 chemotherapy patients 0.331687 Clin Oncol 0.384683 sistema nervioso central 0.357893 patients treated 0.340656 días vo 0.360421 Morrow GR 0.513036 potencial emetógeno 0.502334 Clinical roundtable monograph 0.340704 Adv Hematol Oncol 0.339165	CLICK HERE
1811	National Cancer Institute	Html	es	Descripción del tratamiento de tumores de encéfalo y de médula espinal infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de varios tumores de encéfalo infantiles.	Altekruse SF 0.447856 American Academy 0.440446 Brain Tumor Registry 0.477956 pediatric cancer 0.464838 plexo coroideo 0.50432 largo plazo 0.465315 cancer center 0.498759 Children's National Health 0.432864 Declining childhood 0.43143 astrocitomas pilocíticos 0.47055 Instituto Nacional 0.460068 Reifenberger G 0.447846 World Health Organization 0.488687 Health Organization Classification 0.496391 Pediatric Brain Tumor 0.46738 tumor embrionario 0.530794 SAI Tratamiento 0.438882 tumores glioneuronales papilares 0.533183 Children's Oncology Group 0.486579 Childhood Cancer Survivor 0.446412 SNC primarios 0.433523 central nervous system 0.795553 pdq correspondiente tipo 0.466293 Smith MA 0.441598 Acta Neuropathol 0.450438	long-term survivors 0.443577 tumores papilares 0.526133 Organización Mundial 0.435085 United States 0.447735 subtipo patológico sumario 0.46642 Neuro Oncol 0.509938 PDQ Descripción 0.456005 Pediatr Blood Cancer 0.436965 PDQ Efectos tardíos 0.580122 National Cancer Institute 0.479004 Pollack IF 0.449126 tumor atípico 0.44433 Clin Oncol 0.579132 nervous system tumors 0.447762 sistema nervioso central 0.82435 childhood brain tumors 0.461864 brain tumor 0.932348 Kimmel Comprehensive Cancer 0.433441 Perry A 0.444221 tumores embrionarios 0.61933 newly diagnosed 0.441805 espinal infantiles recién 0.46155 childhood central nervous 0.442376 Wilmot Cancer Center 0.432289	CLICK HERE
1982	National Cancer Institute	Html	es	Tratamiento del cáncer de tiroides (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de tiroides.	glándula tiroides 0.908295 estadios iva 0.233602 siguientes procedimientos 0.206098 ganglios linfáticos.ampliar cáncer 0.716308 hormona tiroidea 0.292738 radioterapia intraoperatoria 0.215525 siguientes aspectos 0.243621 menos.ampliar cáncer 0.315655 gen ret 0.208945 estadio ii 0.465746 enfermedad tiroidea 0.223963 ganglio linfático centinela 0.278708 vía oral 0.205075 rayos x 0.221349 estadio ivb 0.462997 estadio ivc 0.408027 enlace drugs approved 0.226007 ondas sonoras 0.222594 estadio iva 0.373015 órgano fonador 0.446375 National Cancer Institute 0.204974	tiroides causa efectos 0.252932 endocrina múltiple tipo 0.287058 hormonas tiroideas 0.209751 Instituto Nacional 0.209158 PDQ Tratamiento 0.229219 antecedentes familiares 0.2071 pacientes pastillas 0.209381 siguientes funciones 0.210244 Physician Data Query 0.218087 estadio iii 0.401226 centímetros.ampliar cáncer 0.275936 suficiente hormona tiroidea 0.209562 nódulo tiroideo 0.292185 Thyroid Cancer 0.21393 hormona calcitonina 0.209835 pequeña dosis 0.204395 pequeña parte 0.2042 células tiroideas 0.225287 cuerpo.ampliar cáncer 0.277585 nódulos tiroideos 0.301973 tiroides.ampliar cáncer 0.26979	CLICK HERE
3426	National Cancer Institute	Html	es	El uso de la hipertermia en el tratamiento del cáncer	Hoja informativa que explica en qué consiste la hipertermia (el tratamiento de los tumores con altas temperaturas) y sus efectos secundarios.	Lippincott Williams 0.53777 Lancet Oncology 0.561914 Gunderson LL 0.539005 Bast RC Jr 0.559948 Hildebrandt B 0.608355 Zee J 0.537016 undergoing surgical debulking 0.565384 causa efectos 0.537555 Gibbs FA Jr 0.56087 molecular basis 0.53797 intraperitoneal chemotherapy 0.537405 DeVita VT Jr 0.563586 termómetros minúsculos 0.539825 Kufe DW 0.535758 Kapp DS 0.536798 PubMed Abstract 0.959153 general medicamentos 0.53615 numerosos estudios 0.552283 Clinical Oncology 0.559745 Tepper JE 0.538345 International Journal 0.535346 Critical Reviews 0.540202 Isolation perfusion 0.539903 perfusión peritoneal hipertérmica 0.626548 hyperthermic peritoneal perfusion 0.599527	Pingpank JF 0.537893 numerosos obstáculos 0.535929 Libutti SK 0.60375 Carlson RW 0.535964 Wust P 0.612473 Decker Inc 0.534795 consecuencia quemaduras 0.537822 Issels RD 0.537803 combined treatment 0.542204 inserta pequeñas agujas 0.572325 también llamada terapia 0.570859 Churchill Livingstone 0.537458 Hellman S 0.534905 malignant peritoneal mesothelioma 0.597049 promising approach 0.54123 6th ed 0.538756 cuello uterino 0.631745 Alexander HR 0.602298 Clinical Radiation Oncology 0.587129 altas temperaturas 0.793884 Ahlers O 0.540177 Hahn GM 0.536167 Roemer RB 0.538179 Sreenivasa G 0.536365	CLICK HERE
15648	National Cancer Institute	Html	en	NCI Grant Policies	Research grants are subject to a variety of policy requirements. Find highlights of policy announcements or changes specific to NCI.	Large R01s 0.450134 intramural investigators 0.495879 P01 renewal applications 0.616984 comprehensive access 0.459855 research grants 0.682427 specific policy 0.488359 evidence-based approaches 0.457301 human health 0.466536 Access Policy 0.490853 cancer therapy 0.46631 budget request 0.487575 prior approval 0.46826 clinical trials 0.978226 alternative calculation 0.447591 NIH Grants Policy 0.785706 additional information 0.464918 unsolicited R01 applications 0.694664 exceptions 0.333503 NIH GDS policy 0.707591 cooperative agreements 0.455552 research results 0.500906 direct cost requests 0.569063 PARs 0.332254 grants administration policies 0.684335 cancer research continuum 0.601742	NCI-Supported Interventional Clinical 0.650424 non-NIH funded investigators 0.630213 NIH research 0.564712 contracts 0.352239 large R01 payline 0.833282 NCI Clinical Trials 0.784254 genomic research data 0.651702 final results 0.607682 general R01 payline 0.832292 NCI Program Director 0.732659 Scientific Review 0.449688 budget format 0.487382 grantees 0.329888 NIH Guide 0.534988 interventional clinical trials 0.88994 deviation 0.332851 directly impact patient 0.587395 policy announcements 0.520246 Type 0.343808 policy requirements 0.522004 separate NCI payline 0.844339 interventional cancer research 0.663219 prior project period 0.601145 direct cost budget 0.622892	CLICK HERE